{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"immunodeficiency-due-to-selective-anti-polysaccharide-antibody-deficiency","columns":[{"gene":"","key":"population-334d5e568abdc376e410","label":"Immunodeficiency due to selective anti-polysaccharide antibody deficiency","mondoId":"MONDO:0019093","onsetQualifier":null,"originColumnKey":"MONDO:0019093/ORPHA:70593","originalViews":[{"key":"MONDO:0019093/ORPHA:70593","label":"Immunodeficiency due to selective anti-polysaccharide antibody deficiency","scopeLabel":"ORPHA:70593","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["00799326bde5426e7bf982d6de2396c52b0e9b3b495f5cfb634366aad9b0c9ae","047d073889a9cf07b17a5fab364cef69d3663f077617a3c777ad528a3a4b78e0","15f8d4a406aac7e8de069dc934c9c4707a7352bd7eb8c231c25ffe3dc3a1525b","3cd80f83c0f246d92a483daf2250882e409c43c228281cb5e6105ee039341e6c","3cf439e7c3bc5e4c95e36a5a563a5e8a905ad470c7e77e8a59758a7dde61663b","45ea05fc67686802eb741273157e936cdd711204df0d7116d557176e2409ce01","4e2ff9fe98daae85b6dc6f351576067b0ec48327bf5a98056b0f3b45f4ccda38","67181dd5f93fad22a7ef8819d7ec23ccf0084e752ffd86f96d055b96cd6d938c","6b9b7f58f158edc9d0e6759139b63efbcdf05d6cdb0af18f4e7e608626d90cd6","705396a73c3e7b1f456a091ffdf18d0eff86bd332b216e2419c719167d86a1f9","77364ac7260c4c08da296c6fe4d27cfd57cea406d3c9af42e68da274ff9991a0","793da6239e59e2f78b480f8e47a715d5bd5838be35c8d9c6fdc1a193111084c8","82d4e4f269654b4d96dbf1957390d2fe00d57b671cd639360f1d8a26c749f508","a9a8780f990a8411b070057442ac7f930ce151f42942250116741105974ceb8f","bdec2a80aaf31a09be348126a7acc3b51bfd632e6e1774936f080025c4d44ba6","c1e3046220e872ef2f773869ae8f8f779c454999a2601671416c4a5a291d019d","c4f5949ecf7b5814ac6b297dbd0ad56cfa11551c4443ab00fc70aec2f5b888e1","d1db83dc2da1dede6891dcdf3416a60033a3f7f92ed4a2d6b701d4325c66e862","ecf98e29ed62672b40bd296b276ebbb381a44165864af80329d0031f6f487ec0"],"recordQualifiers":{},"scopeLabel":"ORPHA:70593","sourceIds":["ORPHA:70593"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-334d5e568abdc376e410"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0410240","HP:0410242","HP:0410243","HP:0002099","HP:0001047","HP:0410303","HP:0410295"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":19,"sourceGroups":{"orphanet":19}},"features":[{"hpoId":"HP:0410240","label":"Abnormal circulating IgA concentration","primary":true},{"hpoId":"HP:0410242","label":"Abnormal circulating IgG concentration","primary":true},{"hpoId":"HP:0410243","label":"Abnormal circulating IgM concentration","primary":true},{"hpoId":"HP:0002099","label":"Asthma","primary":true},{"hpoId":"HP:0001047","label":"Atopic dermatitis","primary":true},{"hpoId":"HP:0410303","label":"Complete or near-complete absence of specific antibody response to protein-conjugated Haemophilus influenzae type b vaccine","primary":true},{"hpoId":"HP:0410295","label":"Complete or near-complete absence of specific antibody response to tetanus vaccine","primary":true},{"hpoId":"HP:0410300","label":"Complete or near-complete absence of specific antibody response to unconjugated pneumococcus polysaccharide","primary":false},{"hpoId":"HP:0030374","label":"Decreased memory B cell proportion","primary":false},{"hpoId":"HP:0002848","label":"Decreased specific anti-polysaccharide antibody concentration","primary":false},{"hpoId":"HP:0410302","label":"Decreased specific antibody response to protein-conjugated polysaccharide vaccine","primary":false},{"hpoId":"HP:0410299","label":"Decreased specific antibody response to unconjugated polysaccharide vaccine","primary":false},{"hpoId":"HP:0010976","label":"Decreased total B cell count","primary":false},{"hpoId":"HP:0000388","label":"Otitis media","primary":false},{"hpoId":"HP:0007274","label":"Recurrent bacterial meningitis","primary":false},{"hpoId":"HP:0031949","label":"Recurrent bacterial upper respiratory tract infections","primary":false},{"hpoId":"HP:0200117","label":"Recurrent upper and lower respiratory tract infections","primary":false},{"hpoId":"HP:0012384","label":"Rhinitis","primary":false},{"hpoId":"HP:0000246","label":"Sinusitis","primary":false}],"ledeHtml":"Immunodeficiency due to selective anti-polysaccharide antibody deficiency is characterized by normal immunoglobulin levels (including IgG sub-classes) but impaired polysaccharide responsiveness (IPR).","mondoId":"MONDO:0019093","node":{"canonicalSlug":"immunodeficiency-due-to-selective-anti-polysaccharide-antibody-deficiency","comparisons":[{"documentSha256":"797014a4189b15e61ca5d7bab95f354f4bac729aec2597cbab0c20e0170dedc8","key":"legacy-immunodeficiency-due-to-selective-anti-polysaccharide-antibody-deficiency","kind":"legacy","label":"immunodeficiency due to selective anti-polysaccharide antibody deficiency","memberIds":["MONDO:0019093"],"mondoId":"MONDO:0019093","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/immunodeficiency-due-to-selective-anti-polysaccharide-antibody-deficiency.797014a4189b15e61ca5d7bab95f354f4bac729aec2597cbab0c20e0170dedc8.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","matchMethod":"same-ontology-node","name":"immunodeficiency due to selective anti-polysaccharide antibody deficiency","paragraphs":["Immunodeficiency due to selective anti-polysaccharide antibody deficiency is characterized by normal immunoglobulin levels (including IgG sub-classes) but impaired polysaccharide responsiveness (IPR)."],"scope":"exact","source":"MONDO","upstream":"Orphanet:70593","url":"https://monarchinitiative.org/MONDO:0019093"},"ownColumnKeys":["population-334d5e568abdc376e410"],"publication":"published","relationships":[{"kind":"parent","label":"immunodeficiency disease","mondoId":"MONDO:0021094","slug":null}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"Name scope not exact or reviewed","source":"GARD","url":"https://rarediseases.info.nih.gov/diseases/11903"}],"translation":"pending"},"records":[{"frequencyKind":"range","key":"00799326bde5426e7bf982d6de2396c52b0e9b3b495f5cfb634366aad9b0c9ae","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:70593","disease_name":"Immunodeficiency due to selective anti-polysaccharide antibody deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0410299","is_excluded":false,"label":"Decreased specific antibody response to unconjugated polysaccharide vaccine","onset_id":null,"reference":"ORPHA:70593","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"047d073889a9cf07b17a5fab364cef69d3663f077617a3c777ad528a3a4b78e0","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:70593","disease_name":"Immunodeficiency due to selective anti-polysaccharide antibody deficiency","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0410295","is_excluded":true,"label":"Complete or near-complete absence of specific antibody response to tetanus vaccine","onset_id":null,"reference":"ORPHA:70593","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"15f8d4a406aac7e8de069dc934c9c4707a7352bd7eb8c231c25ffe3dc3a1525b","raw":{"aspect":"P","body_system":"respiratory","disease_id":"ORPHA:70593","disease_name":"Immunodeficiency due to selective anti-polysaccharide antibody deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0031949","is_excluded":false,"label":"Recurrent bacterial upper respiratory tract infections","onset_id":null,"reference":"ORPHA:70593","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"3cd80f83c0f246d92a483daf2250882e409c43c228281cb5e6105ee039341e6c","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:70593","disease_name":"Immunodeficiency due to selective anti-polysaccharide antibody deficiency","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0410240","is_excluded":true,"label":"Abnormal circulating IgA concentration","onset_id":null,"reference":"ORPHA:70593","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"3cf439e7c3bc5e4c95e36a5a563a5e8a905ad470c7e77e8a59758a7dde61663b","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"ORPHA:70593","disease_name":"Immunodeficiency due to selective anti-polysaccharide antibody deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0012384","is_excluded":false,"label":"Rhinitis","onset_id":null,"reference":"ORPHA:70593","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"45ea05fc67686802eb741273157e936cdd711204df0d7116d557176e2409ce01","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:70593","disease_name":"Immunodeficiency due to selective anti-polysaccharide antibody deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0410300","is_excluded":false,"label":"Complete or near-complete absence of specific antibody response to unconjugated pneumococcus polysaccharide","onset_id":null,"reference":"ORPHA:70593","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"4e2ff9fe98daae85b6dc6f351576067b0ec48327bf5a98056b0f3b45f4ccda38","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:70593","disease_name":"Immunodeficiency due to selective anti-polysaccharide antibody deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001047","is_excluded":false,"label":"Atopic dermatitis","onset_id":null,"reference":"ORPHA:70593","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"67181dd5f93fad22a7ef8819d7ec23ccf0084e752ffd86f96d055b96cd6d938c","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:70593","disease_name":"Immunodeficiency due to selective anti-polysaccharide antibody deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0002848","is_excluded":false,"label":"Decreased specific anti-polysaccharide antibody concentration","onset_id":null,"reference":"ORPHA:70593","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"6b9b7f58f158edc9d0e6759139b63efbcdf05d6cdb0af18f4e7e608626d90cd6","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:70593","disease_name":"Immunodeficiency due to selective anti-polysaccharide antibody deficiency","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0410242","is_excluded":true,"label":"Abnormal circulating IgG concentration","onset_id":null,"reference":"ORPHA:70593","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"705396a73c3e7b1f456a091ffdf18d0eff86bd332b216e2419c719167d86a1f9","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:70593","disease_name":"Immunodeficiency due to selective anti-polysaccharide antibody deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0410302","is_excluded":false,"label":"Decreased specific antibody response to protein-conjugated polysaccharide vaccine","onset_id":null,"reference":"ORPHA:70593","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"77364ac7260c4c08da296c6fe4d27cfd57cea406d3c9af42e68da274ff9991a0","raw":{"aspect":"P","body_system":"respiratory","disease_id":"ORPHA:70593","disease_name":"Immunodeficiency due to selective anti-polysaccharide antibody deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0200117","is_excluded":false,"label":"Recurrent upper and lower respiratory tract infections","onset_id":null,"reference":"ORPHA:70593","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"793da6239e59e2f78b480f8e47a715d5bd5838be35c8d9c6fdc1a193111084c8","raw":{"aspect":"P","body_system":"respiratory","disease_id":"ORPHA:70593","disease_name":"Immunodeficiency due to selective anti-polysaccharide antibody deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000246","is_excluded":false,"label":"Sinusitis","onset_id":null,"reference":"ORPHA:70593","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"82d4e4f269654b4d96dbf1957390d2fe00d57b671cd639360f1d8a26c749f508","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:70593","disease_name":"Immunodeficiency due to selective anti-polysaccharide antibody deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0410303","is_excluded":false,"label":"Complete or near-complete absence of specific antibody response to protein-conjugated Haemophilus influenzae type b vaccine","onset_id":null,"reference":"ORPHA:70593","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"a9a8780f990a8411b070057442ac7f930ce151f42942250116741105974ceb8f","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:70593","disease_name":"Immunodeficiency due to selective anti-polysaccharide antibody deficiency","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0410243","is_excluded":true,"label":"Abnormal circulating IgM concentration","onset_id":null,"reference":"ORPHA:70593","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"bdec2a80aaf31a09be348126a7acc3b51bfd632e6e1774936f080025c4d44ba6","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:70593","disease_name":"Immunodeficiency due to selective anti-polysaccharide antibody deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0010976","is_excluded":false,"label":"Decreased total B cell count","onset_id":null,"reference":"ORPHA:70593","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c1e3046220e872ef2f773869ae8f8f779c454999a2601671416c4a5a291d019d","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:70593","disease_name":"Immunodeficiency due to selective anti-polysaccharide antibody deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0030374","is_excluded":false,"label":"Decreased memory B cell proportion","onset_id":null,"reference":"ORPHA:70593","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c4f5949ecf7b5814ac6b297dbd0ad56cfa11551c4443ab00fc70aec2f5b888e1","raw":{"aspect":"P","body_system":"ear","disease_id":"ORPHA:70593","disease_name":"Immunodeficiency due to selective anti-polysaccharide antibody deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000388","is_excluded":false,"label":"Otitis media","onset_id":null,"reference":"ORPHA:70593","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"d1db83dc2da1dede6891dcdf3416a60033a3f7f92ed4a2d6b701d4325c66e862","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:70593","disease_name":"Immunodeficiency due to selective anti-polysaccharide antibody deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0007274","is_excluded":false,"label":"Recurrent bacterial meningitis","onset_id":null,"reference":"ORPHA:70593","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"ecf98e29ed62672b40bd296b276ebbb381a44165864af80329d0031f6f487ec0","raw":{"aspect":"P","body_system":"respiratory","disease_id":"ORPHA:70593","disease_name":"Immunodeficiency due to selective anti-polysaccharide antibody deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002099","is_excluded":false,"label":"Asthma","onset_id":null,"reference":"ORPHA:70593","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0019093\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>same-ontology-node</dd><dt>Upstream attribution</dt><dd>Orphanet:70593</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Immunodeficiency due to selective anti-polysaccharide antibody deficiency is characterized by normal immunoglobulin levels (including IgG sub-classes) but impaired polysaccharide responsiveness (IPR).</p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0019093\" rel=\"noreferrer\">MONDO</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"immunodeficiency-due-to-selective-anti-polysaccharide-antibody-deficiency","sourceDocuments":[{"name":"MONDO: immunodeficiency due to selective anti-polysaccharide antibody deficiency","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0019093"}],"sourceNote":"","synonyms":["specific antibody deficiency"],"takeawayHtml":"","title":"immunodeficiency due to selective anti-polysaccharide antibody deficiency"},"schemaVersion":1}
